Wegovy 0.25mg not working: why that's not the problem you think it is

You're four weeks in, the scale hasn't moved, and you're wondering whether this is working

That feeling is common. A question our prescribers hear most weeks is some version of: I've been on Wegovy for a month and nothing's happened, is it working? The short answer is yes, it almost certainly is, just not in the way most people expect at this stage.

Wegovy's titration schedule begins at 0.25mg for a reason. Semaglutide is a GLP-1 receptor agonist, meaning it mimics a gut hormone that signals fullness and slows the rate at which your stomach empties. At the full 2.4mg maintenance dose, that effect is strong enough to produce meaningful, sustained appetite suppression. At 0.25mg, the same mechanism is active, but at a level low enough that your gut can adapt without overwhelming nausea or vomiting. The first four weeks are about your system getting used to a new signal, not about shifting weight.

There is a widespread misconception that if you're not losing weight in the first month, semaglutide simply doesn't work for you. That conclusion is premature at 0.25mg. The NHS patient information for semaglutide is clear that the starting dose is increased after four weeks, and that weight loss is assessed over the longer course of treatment. Your prescriber is the right person to confirm your titration schedule and decide when you are ready to move up.

Why 0.25 semaglutide not working for weight loss is, clinically speaking, the point

The STEP 1 trial (the pivotal study behind Wegovy's licence) showed an average weight reduction of around 15% over 68 weeks at the 2.4mg maintenance dose, published in the New England Journal of Medicine. That result was built on months of dose escalation. Participants spent weeks at each step along the way, and the weight loss accelerated as the dose increased.

Most people begin to notice a meaningful reduction in appetite somewhere around the 1mg mark. At 1.7mg and 2.4mg, the effect on hunger, food preferences and portion size tends to be considerably stronger. This is why how the full dose schedule works matters so much, understanding the shape of the journey makes the early weeks feel purposeful rather than wasted.

It is also worth noting that side effects are most likely to appear when a dose changes. Tolerating 0.25mg well is a positive sign. Some people experience very little nausea at the starter dose and worry they're not responding; that's a normal variation, not a problem. Sensitivity to the medicine and weight-loss response are different things.

If you are concerned your 0.25mg experience seems unusual (very severe nausea, no improvement at all after four weeks, or something that simply doesn't feel right) those are conversations to have with your prescriber directly. Details on how the first dose of Wegovy feels for most people may also help you calibrate what's typical.

What happens after 0.25mg, and when to expect results

After four weeks at 0.25mg, the standard schedule moves to 0.5mg for another four weeks. From there, titration continues at roughly monthly intervals through 1mg, 1.7mg, and finally 2.4mg, with the MHRA-approved 7.2mg dose now available as a further step for eligible patients. The pace is set by your prescriber based on how well you're tolerating each level. Some people find they need longer at a particular dose before moving up; that's a clinical decision, not a setback.

Real-world timelines vary. Many people report that noticeable appetite change arrives gradually, often alongside the dose increases in months two and three. The 68-week STEP 1 trial timeline gives some useful perspective: this is a treatment measured in months, not weeks. Expecting meaningful weight change inside the first four weeks places the bar at the wrong point on the curve.

Lifestyle choices alongside the medicine matter throughout. Protein-adequate meals, staying well hydrated and some form of regular movement all support the process. These don't replace the medicine, they work alongside it. If you want to understand more about how semaglutide affects energy balance beyond just appetite, that detail may be useful context.

For anyone thinking about the cost of continuing treatment, it's worth knowing that ongoing clinical review is part of the process, each repeat prescription involves a clinical re-check, not just an automatic refill. If you'd like a prescriber to review where you are in your journey, check your eligibility and our team can take it from there.